The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%. The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Your trusted source for real-time market insights, expert analysis, and breaking financial news. We deliver actionable updates on global markets, stocks, crypto, and economic trends empowering investors to make informed decisions every day.
Contact us: contact@financeworld-news.com
© Copyright 2025 - financeworld-news.com